awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38969949-1FC014A2-B8F0-4C89-AD11-4BBB7D8DB2FB
Q38969949-1FC014A2-B8F0-4C89-AD11-4BBB7D8DB2FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38969949-1FC014A2-B8F0-4C89-AD11-4BBB7D8DB2FB
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.
P2860
Q38969949-1FC014A2-B8F0-4C89-AD11-4BBB7D8DB2FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38969949-1FC014A2-B8F0-4C89-AD11-4BBB7D8DB2FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c361266ca8ca87ff12519f117675ac388781411d
P2860
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer